Kuo-Hsiung Lee Selected Research

Antiviral Agents (Antivirals)

11/2020	Development of anti-influenza agents from natural products.
11/2020	Recent advances in natural anti-HIV triterpenoids and analogs.
1/2018	Biologically active quinoline and quinazoline alkaloids part II.
12/2010	Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kuo-Hsiung Lee Research Topics

Disease

117	Neoplasms (Cancer) 01/2024 - 10/2002
15	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2003
10	Triple Negative Breast Neoplasms 01/2023 - 01/2017
10	Lung Neoplasms (Lung Cancer) 11/2019 - 08/2003
9	Prostatic Neoplasms (Prostate Cancer) 07/2012 - 11/2002
7	Infections 11/2020 - 01/2004
6	Neoplasm Metastasis (Metastasis) 09/2023 - 11/2007
6	Carcinoma (Carcinomatosis) 03/2010 - 01/2005
5	Acquired Immunodeficiency Syndrome (AIDS) 11/2020 - 04/2006
5	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 07/2003
5	Carcinogenesis 02/2014 - 02/2005
4	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 07/2012
4	Human Influenza (Influenza) 01/2021 - 08/2014
4	Thrombosis (Thrombus) 08/2020 - 06/2008
4	Adenocarcinoma 01/2018 - 05/2004
4	Hepatocellular Carcinoma (Hepatoma) 05/2011 - 11/2007
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2017
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2016
3	HIV Infections (HIV Infection) 09/2021 - 09/2002
3	Adenocarcinoma of Lung 04/2015 - 08/2012
3	Nasopharyngeal Carcinoma 12/2012 - 03/2010
3	Leukemia 10/2012 - 12/2009
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 07/2021
2	Virus Diseases (Viral Diseases) 11/2020 - 01/2011
2	Hypoxia (Hypoxemia) 10/2020 - 09/2015
2	Type 2 Diabetes Mellitus (MODY) 08/2020 - 11/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 01/2012
2	Insulin Resistance 10/2018 - 06/2018
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 04/2018 - 01/2018
2	Inflammation (Inflammations) 01/2017 - 01/2011
2	Arthritis (Polyarthritis) 01/2017 - 08/2014
2	Alzheimer Disease (Alzheimer's Disease) 07/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

15	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 08/2008
11	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2023 - 12/2010
10	AlkaloidsIBA 09/2022 - 09/2004
10	neotanshinlactoneIBA 01/2022 - 11/2004
9	LactonesIBA 01/2023 - 12/2005
8	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 08/2003
8	Proteins (Proteins, Gene)FDA Link 08/2022 - 08/2009
8	SesquiterpenesIBA 01/2022 - 12/2005
7	DiterpenesIBA 08/2022 - 10/2002
7	CurcuminIBA 05/2017 - 11/2002
6	DEET (DET)IBA 01/2023 - 01/2016
6	EstersIBA 01/2020 - 11/2002
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2017
5	deoxyelephantopinIBA 01/2023 - 01/2016
5	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 08/2008
5	Betulinic AcidIBA 11/2019 - 07/2009
5	tylophorineIBA 01/2017 - 07/2007
5	TubulinIBA 01/2017 - 01/2005
5	Epstein-Barr virus early antigenIBA 11/2016 - 09/2004
4	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2022 - 10/2004
4	Antiviral Agents (Antivirals)IBA 11/2020 - 12/2010
4	DiarylheptanoidsIBA 01/2018 - 11/2003
3	Mitochondrial DNA (mtDNA)IBA 01/2023 - 11/2016
3	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 01/2018
3	ChromonesIBA 10/2020 - 12/2010
3	Phosphotransferases (Kinase)IBA 11/2019 - 10/2012
3	AntioxidantsIBA 01/2018 - 09/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2017 - 03/2010
3	FlavonoidsIBA 07/2015 - 06/2008
3	Pancreatic Elastase (Elastase)IBA 08/2014 - 02/2010
3	phenanthreneIBA 02/2014 - 07/2007
3	AndrogensIBA 07/2012 - 11/2003
3	Colchicine FDA LinkGeneric 12/2011 - 01/2005
3	2-phenyl-4-oxohydroquinolineIBA 05/2011 - 07/2005
3	AcidsIBA 10/2009 - 11/2002
3	Androgen Receptors (Androgen Receptor)IBA 04/2006 - 11/2002
3	AcetogeninsIBA 11/2004 - 07/2003
2	Liposomes (Liposome)IBA 09/2023 - 10/2020
2	GL 331IBA 08/2022 - 03/2010
2	PoisonsIBA 08/2022 - 01/2014
2	VemurafenibIBA 01/2022 - 01/2016
2	mezereinIBA 09/2021 - 01/2011
2	Estrogen ReceptorsIBA 07/2021 - 09/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 09/2015
2	aloperineIBA 01/2021 - 03/2016
2	Oseltamivir (Tamiflu)FDA Link 11/2020 - 03/2015
2	Therapeutic UsesIBA 10/2020 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 08/2020 - 11/2016
2	Gefitinib (Iressa)FDA Link 11/2019 - 04/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2019 - 03/2011
2	gnidimacrinIBA 01/2019 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 06/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2017 - 01/2016
2	YXM110IBA 09/2015 - 09/2013
2	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 03/2010
2	Cyclin B1IBA 11/2014 - 02/2010
2	antofineIBA 08/2012 - 07/2011
2	cryptopleurineIBA 08/2012 - 07/2011
2	Superoxides (Superoxide)IBA 06/2012 - 02/2010
2	DDBIBA 06/2012 - 01/2012
2	EthersIBA 01/2012 - 03/2011
2	anthraceneIBA 01/2012 - 01/2009
2	LipopolysaccharidesIBA 01/2012 - 03/2011
2	2-(furan-2-yl)naphthalen-1-olIBA 01/2011 - 06/2009

Therapy/Procedure

15	Therapeutics 09/2023 - 01/2004
6	Drug Therapy (Chemotherapy) 01/2023 - 07/2014
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2020 - 01/2011
2	Immunotherapy 09/2023 - 10/2020